Alnylam Pharmaceuticals
ALNY
#660
Rank
C$42.93 B
Marketcap
$332.90
Share price
-8.38%
Change (1 day)
42.95%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company